Literature DB >> 1592700

The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line.

T Zehavi-Willner1, I Shalit.   

Abstract

Ciprofloxacin was tested for its effect on proliferation of a bladder carcinoma cell line, Jurkat T-cell leukaemia cell line and a normal human foreskin derived from a fibroblast cell line. Cell proliferation was measured by MTT tetrazolium salt colorimetric assay. Proliferation of bladder carcinoma cells was inhibited by ciprofloxacin in a dose and time dependent fashion. Initial inhibition was observed at a concentration of 25 mg/L (approximately 35% inhibition; P greater than 0.01) while 250 mg/L of ciprofloxacin, a concentration achievable in urine following conventional oral treatment, exerted a lytic effect on these cells. A maximum suppressive effect on cell proliferation was reached within the first 24 h of ciprofloxacin addition to cell cultures. The rate of reversal of the inhibition of proliferation was dependent on the initial drug concentration. Exposure of bladder carcinoma cell cultures to 250 mg/L ciprofloxacin resulted in irreversible inhibition of proliferation. Similar results were obtained for the fibroblast cell line and Jurkat T-cell line. The latter being slightly more sensitive towards ciprofloxacin treatment in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592700     DOI: 10.1093/jac/29.3.323

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry.

Authors:  M Rabau; A Nyska; D Dayan
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  In vitro effect of ciprofloxacin and ofloxacin on murine and human colon carcinoma cell lines.

Authors:  I Shalit; N Nasrallah; S Bar-On; M Rabau
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.

Authors:  Tomasz Kloskowski; Sylwia Frąckowiak; Jan Adamowicz; Kamil Szeliski; Marta Rasmus; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  CP-115,953 stimulates cytokine production by lymphocytes.

Authors:  K Riesbeck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

5.  The anti-cancer effects of quinolone antibiotics?

Authors:  M Paul; A Gafter-Gvili; A Fraser; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

6.  Biphasic response of ciprofloxacin in human fibroblast cell cultures.

Authors:  Filiz Hincal; Aylin Gürbay; Alain Favier
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-10

7.  Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.

Authors:  I Fabian; D Reuveni; A Levitov; D Halperin; E Priel; I Shalit
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640

8.  Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures.

Authors:  Tomasz Kloskowski; Kamil Szeliski; Zuzanna Fekner; Marta Rasmus; Paweł Dąbrowski; Aleksandra Wolska; Natalia Siedlecka; Jan Adamowicz; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

9.  Urinary tract infections and reduced risk of bladder cancer in Los Angeles.

Authors:  X Jiang; J E Castelao; S Groshen; V K Cortessis; D Shibata; D V Conti; J-M Yuan; M C Pike; M Gago-Dominguez
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.